Page last updated: 2024-11-06

lysergic acid diethylamide and Pituitary Diseases

lysergic acid diethylamide has been researched along with Pituitary Diseases in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Pituitary Diseases: Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ITURRIZA, FC1
KOCH, OR1

Other Studies

1 other study available for lysergic acid diethylamide and Pituitary Diseases

ArticleYear
EFFECT OF THE ADMINISTRATION OF LYSERGIC ACID DIETHYLAMIDE (LSD) ON THE COLLOID VESICLES OF THE PARS INTERMEDIA OF THE TOAD PITUITARY.
    Endocrinology, 1964, Volume: 75

    Topics: Anura; Colloids; Histology; Lysergic Acid Diethylamide; Pharmacology; Pituitary Diseases; Pituitary

1964